Novo Nordisk (NVO), the maker of the popular GLP-1 medications Wegovy and Ozempic, said potential tariffs on Europe imposed ...

Not all weight loss programs are made equal—to reach a healthy, sustainable weight, personalized programs offer the best ...

Anyone who’s looked at the market in the last couple of weeks will know that there were some events that shook investors.

While geo-political issues looked to be dying down, Donald Trump initiated a tariff war by slapping tariffs on China, Mexico, ...

Donald Trump 's renewed push to take control of Greenland is setting off a high-stakes showdown with Denmark, a small country ...

In the STEP trial, which studied semaglutide for weight loss, 89.6% of patients completing ... a plan to reduce single-use plastics. category Mexico calls U.S. steel and aluminum tariffs 'unjustif ...

Over $600 billion in European goods were imported by the U.S. last year. New tariffs from President Trump will likely hit these popular categories the hardest.

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...

Resmed has its origins in the 1980s, when Sydney sleep expert Dr Colin Sullivan converted a vacuum cleaner to deal with the ...

For example, he proposed 25% tariffs on imports from Canada and Mexico, the two biggest trading ... Lilly could launch another obesity drug, weight-loss pill orforglipron, in early 2026.